Clinical profile of remoxipride - a combined analysis of a comparative double-blind multicentre trial programme
Authors:
- 1 April 1990
- journal article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 82 (S358) , 92-98
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparisonActa Psychiatrica Scandinavica, 1990
- Experiences of long‐term treatment with remoxipride: efficacy and tolerabilityActa Psychiatrica Scandinavica, 1990
- Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.Acta Psychiatrica Scandinavica, 1990
- A controlled dose‐ranging study of remoxipride and haloperidol in schizophrenia ‐ a Canadian multicentre trialActa Psychiatrica Scandinavica, 1990
- Biochemical pharmacology of the atypical neuroleptic remoxiprideActa Psychiatrica Scandinavica, 1990
- Neuropharmacological and behavioural properties of remoxipride in the ratActa Psychiatrica Scandinavica, 1990
- A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.Acta Psychiatrica Scandinavica, 1990
- Safety evaluation in both short‐ and long‐term treatment of schizophrenia with remoxiprideActa Psychiatrica Scandinavica, 1990
- Clinically relevant differences between antipsychotic compoundsActa Psychiatrica Scandinavica, 1990
- A double blind comparative multicentre study of remoxipride and haloperidol in schizophreniaActa Psychiatrica Scandinavica, 1990